Rivastigmine is a dual inhibitor of Acetylcholinesterase (ACE) andButyrylcholinesterase (BuCE), the enzymes that co-regulate synaptic levels ofacetylcholine in Alzheimer’s disease patients. The gene discussed is ACE; the disease is early-onset autosomal dominant Alzheimer disease.